Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model

Tumour testing of the BRCA1/2 genes is routinely performed in patients with different cancer histological subtypes. To accurately identify patients with tumour-detected germline pathogenic variants (PVs) is a relevant issue currently under investigation. This study aims at evaluating the performance...

Descripción completa

Detalles Bibliográficos
Autores principales: Azzollini, Jacopo, Vingiani, Andrea, Agnelli, Luca, Tamborini, Elena, Perrone, Federica, Conca, Elena, Capone, Iolanda, Busico, Adele, Peissel, Bernard, Rosina, Erica, Ducceschi, Monika, Mantiero, Mara, Lopez, Salvatore, Raspagliesi, Francesco, Niger, Monica, Duca, Matteo, Damian, Silvia, Proto, Claudia, de Braud, Filippo, Pruneri, Giancarlo, Manoukian, Siranoush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026437/
https://www.ncbi.nlm.nih.gov/pubmed/35463374
http://dx.doi.org/10.3389/fonc.2022.857515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026437/
https://www.ncbi.nlm.nih.gov/pubmed/35463374
http://dx.doi.org/10.3389/fonc.2022.857515

Ejemplares similares